Skip to main content
PW Medtech Group Limited logo

PW Medtech Group Limited — Investor Relations & Filings

Ticker · 1358 ISIN · KYG7306W1087 LEI · 894500L18EYHNJR6VJ41 HKEX Manufacturing
Filings indexed 783 across all filing types
Latest filing 2024-05-06 Regulatory Filings
Country KY Cayman Islands
Listing HKEX 1358

About PW Medtech Group Limited

http://www.pwmedtech.com

PW Medtech Group Limited is a medical device company engaged in the research, development, production, and sale of advanced infusion therapy products. The company's core portfolio includes specialized infusion sets and related accessories, such as non-PVC and DEHP-free infusion systems, precision filter infusion sets, light-resistant infusion sets, and safety IV catheters. Operating primarily in China, India, the Americas, and Africa, the Group emphasizes patient and clinician safety. Key innovations include positive pressure needleless connectors designed to prevent blood backflow and contamination, and safety-engineered devices utilizing double-layer tubing (TPU/PVC) and high-precision filtration to mitigate needlestick injuries and adverse infusion reactions.

Recent filings

Filing Released Lang Actions
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2024
Regulatory Filings Classification · 95% confidence The document is a monthly return report for movements in securities, specifically detailing authorized and issued share capital, share movements, and confirmations related to securities issued by PW Medtech Group Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The document is structured as a regulatory submission reporting share capital and share issuance movements for the month ended 30 April 2024. It does not contain financial statements, management discussion, or audit information. It is not an announcement of a report publication but a regulatory filing of share capital movements and confirmations. Therefore, it fits best under Regulatory Filings (RNS), which is the category for general regulatory announcements and compliance documents that do not fit other specific categories.
2024-05-06 English
Notification Letter and Request Form to Non-registered Holders
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 26 April 2024 from PW Medtech Group Limited to non-registered shareholders. It announces the publication of the Annual Report 2023 and a Circular related to general mandates for share repurchase and issuance, re-election of retiring directors, and notice of the 2024 Annual General Meeting. The letter provides instructions on how shareholders can access these documents electronically or request printed copies. It does not contain the actual Annual Report or Circular but rather informs shareholders of their availability on the company's and stock exchange's websites. The document also includes a request form for shareholders to indicate their preferred method of receiving future corporate communications. The length is about 11,380 characters, which is relatively short for a full annual report but typical for a notification letter. The content fits the definition of a Report Publication Announcement (RPA) because it announces the publication of reports and related corporate communications without including substantive financial data or the reports themselves.
2024-04-25 English
Notification Letter and Reply Form to Registered Shareholders
Report Publication Announcement Classification · 95% confidence The document is a notification letter dated 26 April 2024 from PW Medtech Group Limited to its registered shareholders. It announces the publication of the Annual Report 2023, a circular relating to proposed general mandates for share repurchase and issuance, proposed re-election of retiring directors, and the notice of the 2024 Annual General Meeting, along with the form of proxy. The letter directs shareholders to the company's website and the stock exchange website to access these documents electronically. It also includes a reply form for shareholders to request printed copies of these corporate communications. The document itself does not contain the full annual report or the circular but serves as a notice of their publication and availability. The document length is about 13,385 characters, which is relatively short for a full annual report but typical for a notification letter. According to the "Menu vs Meal" rule, since this document announces the availability of the annual report and other materials rather than containing the full reports themselves, it should be classified as a Report Publication Announcement (RPA).
2024-04-25 English
Form of Proxy for use at the Annual General Meeting to be held on Friday, June 14, 2024
AGM Information Classification · 95% confidence The document is a Form of Proxy for use at the Annual General Meeting (AGM) of PW Medtech Group Limited, scheduled for June 14, 2024. It includes instructions for shareholders to appoint proxies to vote on resolutions such as adoption of audited financial statements, dividend declaration, re-election of directors, appointment of auditors, and share repurchase and issuance mandates. The content is procedural and related to the conduct of the AGM rather than the AGM presentation materials themselves. This type of document is typically classified as AGM Information (AGM-R) because it is directly related to the AGM process and shareholder voting, but it is not the full Annual Report or the voting results announcement. The document length (7,671 characters) supports it being a detailed proxy form rather than a brief announcement or a full report. Therefore, the appropriate classification is AGM Information (AGM-R).
2024-04-25 English
NOTICE OF THE 2024 ANNUAL GENERAL MEETING
AGM Information Classification · 100% confidence The document is a notice of the 2024 Annual General Meeting (AGM) for PW Medtech Group Limited. It includes details about the meeting date, agenda items such as adoption of audited financial statements, dividend declaration, re-election of directors, authorization of share repurchase and issuance mandates, and procedural notes for shareholders. The document does not contain the actual financial statements or detailed financial analysis but serves as an announcement and invitation to the AGM. The presence of the term 'NOTICE OF THE 2024 ANNUAL GENERAL MEETING' and the detailed agenda confirms it is an AGM notice. Therefore, the document fits the category of AGM Information (AGM-R).
2024-04-25 English
PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES OF THE COMPANY AND PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS OF THE COMPANY AND NOTICE OF THE 2024 ANNUAL GENERA
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a circular from PW Medtech Group Limited dated April 26, 2024, concerning the 2024 Annual General Meeting (AGM). It includes information about proposed granting of general mandates to repurchase and issue shares, re-election of retiring directors, and the notice of the AGM itself. The document contains detailed explanatory statements, director information, and the notice of the AGM, including proxy arrangements. It is not a simple announcement or notice but a comprehensive circular sent to shareholders to inform them about the AGM agenda and related resolutions. This type of document is typically classified as Proxy Solicitation & Information Statement (PSI), as it provides information to shareholders to solicit their votes for the AGM resolutions. It is not an Annual Report (10-K), Earnings Release (ER), or Management Report (MDA), nor is it a simple announcement or voting result declaration. Therefore, the appropriate classification is PSI with high confidence.
2024-04-25 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.